The Substance Abuse and Mental Health Services Administration today issued an advisory offering evidence-based resources to help clinicians assess and treat mental health symptoms and conditions associated with Long COVID, from fatigue and sleep disturbances to depression, anxiety and post-traumatic stress disorder.
 
“Long COVID has a range of burdensome physical symptoms, and can take a toll on a person’s mental health,” said Health and Human Services Secretary Xavier Becerra. “…This advisory helps to raise awareness, especially among primary care practitioners and clinicians who are often the ones treating patients with Long COVID.”

Related News Articles

Headline
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including certain wearable devices) and the…
Blog
As hospitals and health systems look for sustainable and scalable solutions to help address rising behavioral health needs across the country, digital tools…
Headline
Depression and anxiety can increase the risk of a major adverse cardiac event, according to an American Heart Association study published Dec. 17.
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…